Erlotinib Completed Phase 2 Trials for Advanced Adult Primary Liver Cancer / Adult Primary Hepatocellular Carcinoma / Localized Unresectable Adult Primary Liver Cancer / Recurrent Adult Primary Liver Cancer Treatment